ELITE PHARMACEUTICALS INC /NV/ - Recent Material Event

Item 9.01 Financial Statements and Exhibits

d) Exhibits

 

Exhibit No.   Exhibit
     
99.1   Press Release dated December 13, 2012

 

 
 

 

SIGNATURE

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated: December 13, 2012

 

  ELITE PHARMACEUTICALS, INC.
   
  By:  /s/ Chris Dick
 
Title: 
Name: Chris Dick
President & Chief Operating Officer